Updated on 11 November 2013
"We see this project as a terrific opportunity for pharmaceutical exports to grow with fusion of science, technology and business excellence from joining industry, education and research into a productive partnership," said, Director, MIPS Professor Bill Charman.
Mr. Troy Webb, GSK Australia Boronia Site Director, said the collaboration provided fertile ground for further Australian innovation.
"We look for ways to engage new people, who think differently and provide new opportunities. It's about these fresh attitudes as much as about technical knowledge. Being able to work as part of a team: that's a key part of who we are," Mr Webb said.
"It's an exciting project operating at multiple levels of knowledge, science, technology - with operational, communication and translational skills."
The MIPS - GSK collaboration was established in 2009 with USD3.3 million initial funding from the Victorian Science Agenda (VSA) Investment Fund and GSK. Since this, GSK has invested over USD60 million into expanding manufacturing in Victoria.